Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ameloblastoma × trametinib × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Thyroid Carcinoma, Anaplastic 3 Melanoma 3 Glioma 3 Recurrence 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Solid Tumor Cancer 1 Solid Tumor 1 Skin Neoplasms 1 Sexual Dysfunction, Physiological 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Rare Malignant Neoplasm 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neurofibromatosis 1 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Locally Advanced Thyroid Gland Carcinoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia 1 Hematologic Neoplasms 1 Eunuchism 1 Erectile Dysfunction 1

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06653517 2024-10-22

NETCAM

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase 2 Recruiting

Ameloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡